RxDoctor Payments Data

Thomas Westover, MD

Maternal & Fetal Medicine · Pennington, NJNPI 1972609899

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $8,416 of the $11,369 with a category attached, or 74.0%. 11 manufacturers reported payments, led by Biomarin Pharmaceutical Inc. at 28.8% of the total. Among maternal & fetal medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,369in general payments, 2019–2025

Across 25 payments — averaging $454.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biomarin Pharmaceutical Inc.$3K
  • Illumina, Inc.$3K
  • AstraZeneca$2K
  • Bio-rad Laboratories, Inc.$2K
  • Lupin Inc.$952
  • GE HealthCare$155
  • plus $373 from 5 others

What the payments were for

  • Consulting fees$8788%
  • Speaking & faculty fees$8,41674%
  • Travel & lodging$1,0759%
  • Food & beverage$9729%
  • Education$280%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biomarin Pharmaceutical Inc.10$3,279
Illumina, Inc.2$2,990
AstraZeneca1$2,000
Bio-rad Laboratories, Inc.1$1,620
Lupin Inc.2$952
GE HealthCare3$155
Acadia Pharmaceuticals Inc1$118
Agile Therapeutics, Inc.1$108
Pfizer1$100
AMAG Pharmaceuticals, Inc.2$28
Vanda Pharmaceuticals Inc.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,369 in reported general payments places this provider in the 95th percentile of 79 maternal & fetal medicine providers in New Jersey.

See all maternal & fetal medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$3,340
Medicare patients
12
Services billed
68

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other maternal & fetal medicine in Pennington

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →